Avantor, Inc.
AVTR Healthcare Medical Instruments & Supplies
Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024.
- Revenue
- +4.59%
- EPS
- +128.9%
- Free cash flow
- −9.03%
- Total debt
- −4.51%
Quarter to September 2026, against a year earlier
Follow AVTR
Alert me
Avantor, Inc. (AVTR) P/B ratio
As of 5 November 2026, Avantor, Inc. (AVTR) trades at a P/B ratio of 1.8×. Over the past ten years it has ranged from 0.0× (June 2019) to 12.9× (September 2021); the current reading is higher than 20% of that period. That is below the Medical Instruments & Supplies industry median of 2.3× and below the Healthcare sector median of 2.3×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 1.4× | (41.69%) |
| FY2024 | 2.4× | (17.85%) |
| FY2023 | 2.9× | 3.11% |
| FY2022 | 2.8× | (63.58%) |
| FY2021 | 7.8× | (19.75%) |
| FY2020 | 9.7× | 94.50% |
| FY2019 | 5.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Sep 2026 | 1.7× | 46.85% |
| Jun 2026 | 1.2× | 25.44% |
| Mar 2026 | 0.9× | (32.37%) |
| Dec 2025 | 1.4× | (8.23%) |
| 29 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| BLCO Bausch + Lomb Corporation compare | 1.1× |
| COO The Cooper Companies, Inc. compare | 1.5× |
| AVTR Avantor, Inc. | 1.8× |
| BAX Baxter International Inc. compare | 2.0× |
| TFX Teleflex Incorporated compare | 2.3× |
| ALGN Align Technology, Inc. compare | 2.7× |
| SOLV Solventum Corporation compare | 3.1× |
| ATR AptarGroup, Inc. compare | 3.5× |
| RGEN Repligen Corporation compare | 4.6× |
| Medical Instruments & Supplies industry median | 2.3× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on AVTR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement